Some reports identified that PIK3CA mutation promotes the risk of tumor aggressiveness, and the mutation in the exon 9 of PIK3CA has been identified as a helpful indicator for predicting prognosis in EBV-positive GC.171–173 Other studies declared no effective association between PIK3CA mutations and clinical outcome.174,175. This evidence concerns the gene PIK3CA and neoplasm.